Conjunctivitis and Eosinophilia Increasing in AD Patients Using Dupixent
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The AtopicDermatitis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Faiz, S. Giovannelli J, Podevin C, et al. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30825533. Accessed 5.6.19.
- May, B. Increased Frequency of Eosinophilia Examined With Dupilumab in Patients With Atopic Dermatitis. Available at: https://www.dermatologyadvisor.com/home/topics/dermatitis/increased-frequency-eosinophilia-examined-with-dupilumab-in-patients-with-atopic-dermatitis/. Accessed 5.6.19.
- Thyssen, J.P., de Bruin‐Weller, M.S. et al Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion. Available at: https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.15608. Accessed 5.7.19